ALFA Finder
12:21 IST
NSE
Board Meeting Date
SMS Pharmaceuticals Board Meeting Date
SMS Pharmaceuticals has scheduled a board meeting for November 4, 2026, to consider Q2 FY27 unaudited results. This is a routine advance intimation.
SMS Pharmaceuticals Ltd
- Share price
- ₹523.55
- Market cap
- ₹4,641 Cr
- Revenue (annual)
- ₹886.9 Cr
- Net profit (annual)
- ₹102.0 Cr
- P/E (TTM)
- 39.7×Sector 43.8×
- Promoter holding
- 68.07%+0.00% QoQ
- FII holding
- 1.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Legal & Regulatory 5Financial Results 4Earnings Call 4Results Update 3Board Meeting Date 3Annual General Meeting 3Other Announcement 2Management Change 2Price Movement Clarification 1Dividend 1Debt & Borrowing 1Credit Rating 1Capital Structure Change 1Board Meeting Outcome 1Annual Report 1
Time
3 announcements with these filters
15:39 IST
BSE
Board Meeting Date
SMS Pharmaceuticals Board Meeting Date
SMS Pharmaceuticals has scheduled a board meeting for August 1, 2026, to consider and approve the financial results for the quarter ended June 30, 2026.
10:37 IST
NSE
Board Meeting Date
SMS Pharmaceuticals Board Meeting Date
SMS Pharmaceuticals scheduled a board meeting for May 22, 2026, to approve annual audited results and final dividend. Trading window remains closed until May 24, 2026.